Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 9/20 | 0.69 |
| ▸ | CCNK | O75909 | 7/20 | 0.69 |
| ▸ | CCNT1 | O60563 | 14/20 | 0.65 |
| ▸ | CDK14 | O94921 | 1/20 | 0.53 |
| ▸ | CDK1 | P06493 | 1/20 | 0.53 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.53 |
| ▸ | CDK2 | P24941 | 1/20 | 0.53 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.53 |
| ▸ | CDK16 | Q00536 | 1/20 | 0.53 |
| ▸ | CDK17 | Q00537 | 1/20 | 0.53 |
| ▸ | CDK18 | Q07002 | 1/20 | 0.53 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8612530 | 1.00 | CDK9 (0.69) | CDK9CCNKCCNT1CDK14CDK1 | |
| SCHEMBL8612703 | 0.94 | CDK9 (0.60) | CDK9CCNKCCNT1CDK14CDK1 | |
| SCHEMBL8614334 | 0.94 | CDK9 (0.60) | CDK9CCNKCCNT1CDK14CDK1 | |
| SCHEMBL8629156 | 0.92 | CDK9 (0.61) | CDK9CCNKCCNT1CDK14CDK1 | |
| SCHEMBL8627348 | 0.92 | CDK9 (0.61) | CDK9CCNKCCNT1CDK14CDK1 | |
| SCHEMBL8626354 | 0.89 | CDK9 (0.69) | CDK9CCNKCCNT1CDK14CDK1 | |
| SCHEMBL8628299 | 0.89 | CDK9 (0.69) | CDK9CCNKCCNT1CDK14CDK1 | |
| SCHEMBL8798436 | 0.88 | CCNT1 (0.69) | CDK9CCNKCCNT1CDK14CDK1 | |
| SCHEMBL8797698 | 0.88 | CCNT1 (0.69) | CDK9CCNKCCNT1CDK14CDK1 | |
| SCHEMBL8626137 | 0.87 | CDK9 (0.57) | CDK9CCNKCCNT1CDK14CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012066070-A1 | 3-(AMINOARYL)-PYRIDINE COMPOUNDS | NOVARTIS AG (CH) | 2012-05-24 | — | — | WO | disclosed |